Editor's Choice – Focused Update on Patients Treated with the Nellix EndoVascular Aneurysm Sealing (EVAS) System from the European Society for Vascular Surgery (ESVS) Abdominal Aortic Aneurysm Clinical Practice Guidelines

ESVS AAA Guidelines Writing Committee; ESVS guidelines steering committee

doi:10.1016/j.ejvs.2022.12.031

Editor's Choice – Focused Update on Patients Treated with the Nellix EndoVascular Aneurysm Sealing (EVAS) System from the European Society for Vascular Surgery (ESVS) Abdominal Aortic Aneurysm Clinical Practice Guidelines

ESVS AAA Guidelines Writing Committee, ESVS guidelines steering committee

Bristol Medical School (THS)

Research output: Contribution to journal › Review article (Academic Journal) › peer-review

Abstract

OBJECTIVE: To provide guidance on the surveillance and management of patients treated with Endovascular Aneurysm Seal (EVAS).

METHOD: Based on a scoping review of risk for late serious aortic-related adverse events in patients treated with EVAS for AAA, the European Society for Vascular Surgery (ESVS) AAA Clinical Practice Guidelines Writing Committee agreed on recommendations graded according to the European Society of Cardiology (ESC) grading system.

RESULTS: EVAS has a very high incidence of late endograft migration resulting in proximal type 1 endoleak with risk of rupture, requiring open conversion with device explant. The reported mortality for elective explantation varies between 0% and 14%, while acute conversion for rupture has a very dismal prognosis with 67-75% mortality.

CONCLUSION: It is recommended that all patients in whom a Nellix device has been implanted should be identified, properly informed and enrolled in enhanced surveillance. If device failure is detected, early elective device explant should be considered in surgically fit patients.

Original language	English
Pages (from-to)	320-322
Number of pages	3
Journal	European Journal of Vascular and Endovascular Surgery
Volume	65
Issue number	3
Early online date	6 Jan 2023
DOIs	https://doi.org/10.1016/j.ejvs.2022.12.031
Publication status	E-pub ahead of print - 6 Jan 2023

Bibliographical note

Publisher Copyright:
© 2023 The Author(s)

Access to Document

10.1016/j.ejvs.2022.12.031Licence: CC BY

Handle.net

Persistent link

Fingerprint

Dive into the research topics of 'Editor's Choice – Focused Update on Patients Treated with the Nellix EndoVascular Aneurysm Sealing (EVAS) System from the European Society for Vascular Surgery (ESVS) Abdominal Aortic Aneurysm Clinical Practice Guidelines'. Together they form a unique fingerprint.

Cite this

ESVS AAA Guidelines Writing Committee, & ESVS guidelines steering committee (2023). Editor's Choice – Focused Update on Patients Treated with the Nellix EndoVascular Aneurysm Sealing (EVAS) System from the European Society for Vascular Surgery (ESVS) Abdominal Aortic Aneurysm Clinical Practice Guidelines. European Journal of Vascular and Endovascular Surgery, 65(3), 320-322. https://doi.org/10.1016/j.ejvs.2022.12.031

ESVS AAA Guidelines Writing Committee ; ESVS guidelines steering committee. / Editor's Choice – Focused Update on Patients Treated with the Nellix EndoVascular Aneurysm Sealing (EVAS) System from the European Society for Vascular Surgery (ESVS) Abdominal Aortic Aneurysm Clinical Practice Guidelines. In: European Journal of Vascular and Endovascular Surgery. 2023 ; Vol. 65, No. 3. pp. 320-322.

@article{39412db498c643e0b99e8cae22438f16,

title = "Editor's Choice – Focused Update on Patients Treated with the Nellix EndoVascular Aneurysm Sealing (EVAS) System from the European Society for Vascular Surgery (ESVS) Abdominal Aortic Aneurysm Clinical Practice Guidelines",

abstract = "OBJECTIVE: To provide guidance on the surveillance and management of patients treated with Endovascular Aneurysm Seal (EVAS).METHOD: Based on a scoping review of risk for late serious aortic-related adverse events in patients treated with EVAS for AAA, the European Society for Vascular Surgery (ESVS) AAA Clinical Practice Guidelines Writing Committee agreed on recommendations graded according to the European Society of Cardiology (ESC) grading system.RESULTS: EVAS has a very high incidence of late endograft migration resulting in proximal type 1 endoleak with risk of rupture, requiring open conversion with device explant. The reported mortality for elective explantation varies between 0% and 14%, while acute conversion for rupture has a very dismal prognosis with 67-75% mortality.CONCLUSION: It is recommended that all patients in whom a Nellix device has been implanted should be identified, properly informed and enrolled in enhanced surveillance. If device failure is detected, early elective device explant should be considered in surgically fit patients.",

author = "Boyle, {J R} and N Tsilimparis and {Van Herzeele}, I and A Wanhainen and {ESVS AAA Guidelines Writing Committee} and {ESVS guidelines steering committee} and Twine, {Chris P}",

note = "Publisher Copyright: {\textcopyright} 2023 The Author(s)",

year = "2023",

month = jan,

day = "6",

doi = "10.1016/j.ejvs.2022.12.031",

language = "English",

volume = "65",

pages = "320--322",

journal = "European Journal of Vascular and Endovascular Surgery",

issn = "1078-5884",

publisher = "W.B. Saunders",

number = "3",

}

ESVS AAA Guidelines Writing Committee & ESVS guidelines steering committee 2023, 'Editor's Choice – Focused Update on Patients Treated with the Nellix EndoVascular Aneurysm Sealing (EVAS) System from the European Society for Vascular Surgery (ESVS) Abdominal Aortic Aneurysm Clinical Practice Guidelines', European Journal of Vascular and Endovascular Surgery, vol. 65, no. 3, pp. 320-322. https://doi.org/10.1016/j.ejvs.2022.12.031

Editor's Choice – Focused Update on Patients Treated with the Nellix EndoVascular Aneurysm Sealing (EVAS) System from the European Society for Vascular Surgery (ESVS) Abdominal Aortic Aneurysm Clinical Practice Guidelines. / ESVS AAA Guidelines Writing Committee; ESVS guidelines steering committee.
In: European Journal of Vascular and Endovascular Surgery, Vol. 65, No. 3, 06.01.2023, p. 320-322.

Research output: Contribution to journal › Review article (Academic Journal) › peer-review

TY - JOUR

T1 - Editor's Choice – Focused Update on Patients Treated with the Nellix EndoVascular Aneurysm Sealing (EVAS) System from the European Society for Vascular Surgery (ESVS) Abdominal Aortic Aneurysm Clinical Practice Guidelines

AU - Boyle, J R

AU - Tsilimparis, N

AU - Van Herzeele, I

AU - Wanhainen, A

AU - ESVS AAA Guidelines Writing Committee

AU - ESVS guidelines steering committee

AU - Twine, Chris P

PY - 2023/1/6

Y1 - 2023/1/6

N2 - OBJECTIVE: To provide guidance on the surveillance and management of patients treated with Endovascular Aneurysm Seal (EVAS).METHOD: Based on a scoping review of risk for late serious aortic-related adverse events in patients treated with EVAS for AAA, the European Society for Vascular Surgery (ESVS) AAA Clinical Practice Guidelines Writing Committee agreed on recommendations graded according to the European Society of Cardiology (ESC) grading system.RESULTS: EVAS has a very high incidence of late endograft migration resulting in proximal type 1 endoleak with risk of rupture, requiring open conversion with device explant. The reported mortality for elective explantation varies between 0% and 14%, while acute conversion for rupture has a very dismal prognosis with 67-75% mortality.CONCLUSION: It is recommended that all patients in whom a Nellix device has been implanted should be identified, properly informed and enrolled in enhanced surveillance. If device failure is detected, early elective device explant should be considered in surgically fit patients.

AB - OBJECTIVE: To provide guidance on the surveillance and management of patients treated with Endovascular Aneurysm Seal (EVAS).METHOD: Based on a scoping review of risk for late serious aortic-related adverse events in patients treated with EVAS for AAA, the European Society for Vascular Surgery (ESVS) AAA Clinical Practice Guidelines Writing Committee agreed on recommendations graded according to the European Society of Cardiology (ESC) grading system.RESULTS: EVAS has a very high incidence of late endograft migration resulting in proximal type 1 endoleak with risk of rupture, requiring open conversion with device explant. The reported mortality for elective explantation varies between 0% and 14%, while acute conversion for rupture has a very dismal prognosis with 67-75% mortality.CONCLUSION: It is recommended that all patients in whom a Nellix device has been implanted should be identified, properly informed and enrolled in enhanced surveillance. If device failure is detected, early elective device explant should be considered in surgically fit patients.

U2 - 10.1016/j.ejvs.2022.12.031

DO - 10.1016/j.ejvs.2022.12.031

M3 - Review article (Academic Journal)

C2 - 36623763

SN - 1078-5884

VL - 65

SP - 320

EP - 322

JO - European Journal of Vascular and Endovascular Surgery

JF - European Journal of Vascular and Endovascular Surgery

IS - 3

ER -

ESVS AAA Guidelines Writing Committee, ESVS guidelines steering committee. Editor's Choice – Focused Update on Patients Treated with the Nellix EndoVascular Aneurysm Sealing (EVAS) System from the European Society for Vascular Surgery (ESVS) Abdominal Aortic Aneurysm Clinical Practice Guidelines. European Journal of Vascular and Endovascular Surgery. 2023 Jan 6;65(3):320-322. Epub 2023 Jan 6. doi: 10.1016/j.ejvs.2022.12.031